PTC Therapeutics | PTCT - Zysk Z Działalności Operacyjnej





Zysk Z Działalności Operacyjnej Zmiana Data
Acadia Pharmaceuticals USD 37.84M 42.45M 2026-06
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amgen USD 4.61B 777M 2026-06
BioCryst Pharmaceuticals USD 98.46M 161.92M 2026-06
Biogen USD -243.8M 758.1M 2026-06
BioMarin Pharmaceutical USD 105.6M 24.04M 2026-06
Cytokinetics USD -179.17M 2.05M 2026-06
Daiichi Sankyo JPY 85.1B 4.44B 2026-06
Enanta Pharmaceuticals USD -23.54M 98.15M 2024-12
Gilead Sciences USD 3.85B 1.17B 2026-06
Incyte USD 700.4M 376.22M 2026-06
Ionis Pharmaceuticals USD -102.29M 15.71M 2026-06
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Novartis USD 4.75B 515M 2026-06
Pfizer USD 667M 4.32B 2026-06
PTC Therapeutics USD 45.89M 127.51M 2026-03
Puma Biotechnology USD 22.08M 24.26M 2024-09
Roche Holding CHF 11.46B 1.91B 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Sarepta Therapeutics USD 13.29M 345.14M 2026-06
TG Therapeutics USD 21.67M 13.12M 2026-06
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06
Xencor USD -36.6M 41.26M 2026-06